Contact us   |  

Diagnosis of Bone Marrow Failure: inherited versus acquired in adult

Diagnosis of Bone Marrow Failure: inherited versus acquired in adult

08/02/2022 13:00

Speakers: Tim H. Brümmendorf

Target: Health professionals
Subnetworks: Bone marrow failure
Disease Groups: Paroxysmal nocturnal hemoglobinuria, Rare acquired aplastic anemia (Other than PNH)

Since 2009, Prof. Tim Brümmendorf is head of the Department of Hematology and Oncology at University Hospital Aachen, and director of the Center for Integrated Oncology Aachen (CIOA), Germany, which is part of the Cancer Center Network CIOABcD, a member of the German
Comprehensive Cancer Centers (CCC) of Excellence funded by the Deutsche Krebshilfe (DKH).

He earned his medical degree from the University of Heidelberg, Germany. He did his residency in haematology, oncology, and immunology at University Hospital Tübingen, Germany, followed by a post-doctoral research fellowship at the Terry Fox Laboratory, Vancouver, BC, Canada.
In 2004, he received an appointment as attending and then deputy head, Department of Hematology and Oncology, University Hospital Eppendorf, Hamburg, Germany. In Hamburg, he was co-founder of the University Cancer Center Hamburg (UCCH).

Prof Brümmendorf's research focus is on translational and clinical studies in the field of chronic myelogenous leukaemia, myeloproliferative neoplasms, hereditary and acquired bone marrow failure and myelodysplastic syndromes.

He serves as a referee for several international scientific journals and funding organizations. Prof Brümmendorf is a member of the German Cancer Society (DKG), the German Society of Hematology and Oncology (DGHO), and the American Society of Hematology (ASH) and
current chair of the German Association of Academic Hematology and Oncology (VUHO).

Registration is closed for this webinar